These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

432 related articles for article (PubMed ID: 32843547)

  • 21. CADM1 is essential for KSHV-encoded vGPCR-and vFLIP-mediated chronic NF-κB activation.
    Hunte R; Alonso P; Thomas R; Bazile CA; Ramos JC; van der Weyden L; Dominguez-Bendala J; Khan WN; Shembade N
    PLoS Pathog; 2018 Apr; 14(4):e1006968. PubMed ID: 29698475
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ago HITS-CLIP expands understanding of Kaposi's sarcoma-associated herpesvirus miRNA function in primary effusion lymphomas.
    Haecker I; Gay LA; Yang Y; Hu J; Morse AM; McIntyre LM; Renne R
    PLoS Pathog; 2012; 8(8):e1002884. PubMed ID: 22927820
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Triptolide decreases expression of latency-associated nuclear antigen 1 and reduces viral titers in Kaposi's sarcoma-associated and herpesvirus-related primary effusion lymphoma cells.
    Long C; Guo W; Zhou H; Wang J; Wang H; Sun X
    Int J Oncol; 2016 Apr; 48(4):1519-30. PubMed ID: 26821279
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Kaposi's Sarcoma-Associated Herpesvirus Infection Induces the Expression of Neuroendocrine Genes in Endothelial Cells.
    Valiya Veettil M; Krishna G; Roy A; Ghosh A; Dutta D; Kumar B; Chakraborty S; Anju TR; Sharma-Walia N; Chandran B
    J Virol; 2020 Mar; 94(8):. PubMed ID: 31969437
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CCAAT/enhancer-binding protein-alpha is induced during the early stages of Kaposi's sarcoma-associated herpesvirus (KSHV) lytic cycle reactivation and together with the KSHV replication and transcription activator (RTA) cooperatively stimulates the viral RTA, MTA, and PAN promoters.
    Wang SE; Wu FY; Yu Y; Hayward GS
    J Virol; 2003 Sep; 77(17):9590-612. PubMed ID: 12915572
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression Ratios of the Antiapoptotic BCL2 Family Members Dictate the Selective Addiction of Kaposi's Sarcoma-Associated Herpesvirus-Transformed Primary Effusion Lymphoma Cell Lines to MCL1.
    Dunham D; Viswanathan P; Gill J; Manzano M
    J Virol; 2022 Dec; 96(23):e0136022. PubMed ID: 36416587
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen dysregulates expression of MCL-1 by targeting FBW7.
    Kim YJ; Kim Y; Kumar A; Kim CW; Toth Z; Cho NH; Lee HR
    PLoS Pathog; 2021 Jan; 17(1):e1009179. PubMed ID: 33471866
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Replication Machinery of Kaposi's Sarcoma-associated Herpesvirus and Drug Discovery Research].
    Watanabe T; Fujimuro M
    Yakugaku Zasshi; 2019; 139(1):69-73. PubMed ID: 30606932
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Kaposi's sarcoma-associated herpesvirus vIRF2 protein utilizes an IFN-dependent pathway to regulate viral early gene expression.
    Koch S; Damas M; Freise A; Hage E; Dhingra A; Rückert J; Gallo A; Kremmer E; Tegge W; Brönstrup M; Brune W; Schulz TF
    PLoS Pathog; 2019 May; 15(5):e1007743. PubMed ID: 31059555
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Deregulation of HDAC5 by Viral Interferon Regulatory Factor 3 Plays an Essential Role in Kaposi's Sarcoma-Associated Herpesvirus-Induced Lymphangiogenesis.
    Lee HR; Li F; Choi UY; Yu HR; Aldrovandi GM; Feng P; Gao SJ; Hong YK; Jung JU
    mBio; 2018 Jan; 9(1):. PubMed ID: 29339432
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The RNA quality control pathway nonsense-mediated mRNA decay targets cellular and viral RNAs to restrict KSHV.
    Zhao Y; Ye X; Shehata M; Dunker W; Xie Z; Karijolich J
    Nat Commun; 2020 Jul; 11(1):3345. PubMed ID: 32620802
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Kaposi's Sarcoma-Associated Herpesvirus Viral Interleukin-6 Signaling Upregulates Integrin β3 Levels and Is Dependent on STAT3.
    Rivera-Soto R; Dissinger NJ; Damania B
    J Virol; 2020 Feb; 94(5):. PubMed ID: 31801855
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epstein-Barr virus enhances genome maintenance of Kaposi sarcoma-associated herpesvirus.
    Bigi R; Landis JT; An H; Caro-Vegas C; Raab-Traub N; Dittmer DP
    Proc Natl Acad Sci U S A; 2018 Nov; 115(48):E11379-E11387. PubMed ID: 30429324
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The viral interferon-regulatory factor-3 is required for the survival of KSHV-infected primary effusion lymphoma cells.
    Wies E; Mori Y; Hahn A; Kremmer E; Stürzl M; Fleckenstein B; Neipel F
    Blood; 2008 Jan; 111(1):320-7. PubMed ID: 17890449
    [TBL] [Abstract][Full Text] [Related]  

  • 35. X-box binding protein 1 induces the expression of the lytic cycle transactivator of Kaposi's sarcoma-associated herpesvirus but not Epstein-Barr virus in co-infected primary effusion lymphoma.
    Lai IY; Farrell PJ; Kellam P
    J Gen Virol; 2011 Feb; 92(Pt 2):421-31. PubMed ID: 20980528
    [TBL] [Abstract][Full Text] [Related]  

  • 36. SUMO Modification of Histone Demethylase KDM4A in Kaposi's Sarcoma-Associated Herpesvirus-Induced Primary Effusion Lymphoma.
    Yeh WW; Chen YQ; Yang WS; Hong YC; Kao S; Liu TT; Chen TW; Chang L; Chang PC
    J Virol; 2022 Aug; 96(16):e0075522. PubMed ID: 35914074
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Next-Generation Sequencing Analysis Reveals Differential Expression Profiles of MiRNA-mRNA Target Pairs in KSHV-Infected Cells.
    Viollet C; Davis DA; Reczko M; Ziegelbauer JM; Pezzella F; Ragoussis J; Yarchoan R
    PLoS One; 2015; 10(5):e0126439. PubMed ID: 25942495
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pathological Features of Kaposi's Sarcoma-Associated Herpesvirus Infection.
    Katano H
    Adv Exp Med Biol; 2018; 1045():357-376. PubMed ID: 29896675
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oncolytic Reactivation of KSHV as a Therapeutic Approach for Primary Effusion Lymphoma.
    Zhou F; Shimoda M; Olney L; Lyu Y; Tran K; Jiang G; Nakano K; Davis RR; Tepper CG; Maverakis E; Campbell M; Li Y; Dandekar S; Izumiya Y
    Mol Cancer Ther; 2017 Nov; 16(11):2627-2638. PubMed ID: 28847988
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Azidothymidine Sensitizes Primary Effusion Lymphoma Cells to Kaposi Sarcoma-Associated Herpesvirus-Specific CD4+ T Cell Control and Inhibits vIRF3 Function.
    Williamson SJ; Nicol SM; Stürzl M; Sabbah S; Hislop AD
    PLoS Pathog; 2016 Nov; 12(11):e1006042. PubMed ID: 27893813
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.